When a dosage form or an API is introduced to the gastrointestinal tract, or dissolution media mimicking it, a transformation from a metastable to a more stable form with lower solubility and bioavailability is possible.
Jakko Aaltonen
Advertisement
Articles by Jakko Aaltonen
Advertisement
Latest Updated Articles
Monitoring of phase transformations during processing of solid dosage formsPublished: April 1st 2007 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
